Literature DB >> 25797163

Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.

Thuy Nguyen1, Nadezhda German1, Ann M Decker1, Jun-Xu Li2, Jenny L Wiley1, Brian F Thomas1, Terry P Kenakin3, Yanan Zhang1.   

Abstract

A series of substituted 1H-indole-2-carboxamides structurally related to compounds Org27569 (1), Org29647 (2) and Org27759 (3) were synthesized and evaluated for CB1 allosteric modulating activity in calcium mobilization assays. Structure-activity relationship studies showed that the modulation potency of this series at the CB1 receptor was enhanced by the presence of a diethylamino group at the 4-position of the phenyl ring, a chloro or fluoro group at the C5 position and short alkyl groups at the C3 position on the indole ring. The most potent compound (45) had an IC₅₀ value of 79 nM which is ∼2.5 and 10 fold more potent than the parent compounds 3 and 1, respectively. These compounds appeared to be negative allosteric modulators at the CB1 receptor and dose-dependently reduced the Emax of agonist CP55,940. These analogs may provide the basis for further optimization and use of CB1 allosteric modulators.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allosteric modulators; CB1 receptor; Org compounds; Structure–activity relationship

Mesh:

Substances:

Year:  2015        PMID: 25797163      PMCID: PMC4547606          DOI: 10.1016/j.bmc.2015.02.058

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

1.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

Review 2.  Cannabinoid receptors as therapeutic targets.

Authors:  Ken Mackie
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

Review 3.  Allosterism and cannabinoid CB(1) receptors: the shape of things to come.

Authors:  Ruth A Ross
Journal:  Trends Pharmacol Sci       Date:  2007-11       Impact factor: 14.819

4.  Diphenyl purine derivatives as peripherally selective cannabinoid receptor 1 antagonists.

Authors:  Alan Fulp; Katherine Bortoff; Yanan Zhang; Herbert Seltzman; James Mathews; Rodney Snyder; Tim Fennell; Rangan Maitra
Journal:  J Med Chem       Date:  2012-11-09       Impact factor: 7.446

5.  Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor.

Authors:  Kwang H Ahn; Mariam M Mahmoud; Sushma Samala; Dai Lu; Debra A Kendall
Journal:  J Neurochem       Date:  2013-01-07       Impact factor: 5.372

6.  PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.

Authors:  J G Horswill; U Bali; S Shaaban; J F Keily; P Jeevaratnam; A J Babbs; C Reynet; P Wong Kai In
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 7.  Cannabinoid physiology and pharmacology: 30 years of progress.

Authors:  Allyn C Howlett; Christopher S Breivogel; Steven R Childers; Samuel A Deadwyler; Robert E Hampson; Linda J Porrino
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

8.  Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats.

Authors:  Li Jing; Yanyan Qiu; Yanan Zhang; Jun-Xu Li
Journal:  Drug Alcohol Depend       Date:  2014-08-17       Impact factor: 4.492

Review 9.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Arthur Christopoulos; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

10.  Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.

Authors:  Fabricio A Pamplona; Juliano Ferreira; Octávio Menezes de Lima; Filipe Silveira Duarte; Allisson Freire Bento; Stefânia Forner; Jardel G Villarinho; Luigi Bellocchio; Luigi Bellochio; Carsten T Wotjak; Raissa Lerner; Krisztina Monory; Beat Lutz; Claudio Canetti; Isabelle Matias; João Batista Calixto; Giovanni Marsicano; Marilia Z P Guimarães; Reinaldo N Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

View more
  15 in total

1.  Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists.

Authors:  Thuy Nguyen; Ann M Decker; Tiffany L Langston; Kelly M Mathews; Justin N Siemian; Jun-Xu Li; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2017-08-09       Impact factor: 4.418

Review 2.  Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.

Authors:  Leepakshi Khurana; Ken Mackie; Daniele Piomelli; Debra A Kendall
Journal:  Neuropharmacology       Date:  2017-05-17       Impact factor: 5.250

Review 3.  Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.

Authors:  Thuy Nguyen; Jun-Xu Li; Brian F Thomas; Jenny L Wiley; Terry P Kenakin; Yanan Zhang
Journal:  Med Res Rev       Date:  2016-11-23       Impact factor: 12.944

Review 4.  Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.

Authors:  Samuel D Banister; Kaavya Krishna Kumar; Vineet Kumar; Brian K Kobilka; Sanjay V Malhotra
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

5.  Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.

Authors:  Thuy Nguyen; Thomas F Gamage; Ann M Decker; Daniel Barrus; Tiffany L Langston; Jun-Xu Li; Brian F Thomas; Yanan Zhang
Journal:  J Med Chem       Date:  2019-10-24       Impact factor: 7.446

6.  Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.

Authors:  Thuy Nguyen; Nadezhda German; Ann M Decker; Tiffany L Langston; Thomas F Gamage; Charlotte E Farquhar; Jun-Xu Li; Jenny L Wiley; Brian F Thomas; Yanan Zhang
Journal:  J Med Chem       Date:  2017-08-18       Impact factor: 7.446

Review 7.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

8.  Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior.

Authors:  Thuy Nguyen; Thomas F Gamage; David B Finlay; Ann M Decker; Tiffany L Langston; Daniel Barrus; Michelle Glass; Jun-Xu Li; Terry P Kenakin; Yanan Zhang
Journal:  J Med Chem       Date:  2021-12-20       Impact factor: 7.446

Review 9.  Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

Authors:  Eric A Wold; Jianping Chen; Kathryn A Cunningham; Jia Zhou
Journal:  J Med Chem       Date:  2018-08-28       Impact factor: 7.446

10.  Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.

Authors:  Chang-Jiang Qiao; Hamed I Ali; Kwang H Ahn; Srikanth Kolluru; Debra A Kendall; Dai Lu
Journal:  Eur J Med Chem       Date:  2016-05-24       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.